Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs

Authors

Pierre Mangin (ORCID: https://orcid.org/0000-0001-9522-6261)
Martine Jandrot‐Perrus (ORCID: https://orcid.org/0000-0002-8450-9247)

Institutions

Inserm (FR)
Université Paris Cité (FR)
Université de Strasbourg (FR)

Publication Details

Journal: European Heart Journal
Published: 2025-03-06
DOI: https://doi.org/10.1093/eurheartj/ehaf160
Citations: 3
Primary Topic: Peptidase Inhibition and Analysis
Type: article
Field-Weighted Citation Impact: 3.14

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs

Pierre Mangin, Martine Jandrot‐Perrus

Mar 6, 2025

3 citations

European Heart Journal

Peptidase Inhibition and Analysis

3.14

article

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs

Pierre Mangin, Martine Jandrot‐Perrus

March 6, 2025article en

3 citations

Abstract

No abstract available for this paper.

European Heart JournalVol. 46(28)

Inserm (FR), Université Paris Cité (FR), Université de Strasbourg (FR)

Zero hunger

Openalex Percentile: Top 9%

Peptidase Inhibition and Analysis

3.14

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs — Pierre Mangin, Martine Jandrot‐Perrus · European Heart Journal (2025) | TGRS Research Map | TGRS